Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for Alcohol Withdrawal and Craving
NCT07148843Phase 3Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Oct 2026
- Primary completion
- Oct 2030
- Countries
- 1
01
Overview
Phase 3, randomised trial of cannabidiol in alcohol withdrawal syndrome (AWS) and alcohol use disorder (AUD) (3 arms), sponsored by Johns Hopkins University. Primary endpoints: Peak score on the Alcohol Withdrawal Symptom Checklist at 4 days, Peak score on the Clinical Institute Withdrawal Assessment for Alcohol, revised at 4 days and 2 more. Started Oct 2026; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
alcohol withdrawal syndrome (AWS)alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT07148843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07148843.